# TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

> **NCT01090037** · PHASE2,PHASE3 · COMPLETED · sponsor: **Toray Industries, Inc** · enrollment: 892 (actual)

## Conditions studied

- Chronic Renal Failure
- Glomerular Disease
- Nephrosclerosis

## Interventions

- **DRUG:** TRK-100STP high dose
- **DRUG:** TRK-100STP low dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01090037
- **Lead sponsor:** Toray Industries, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-08
- **Final completion:** 2015-01
- **Target enrollment:** 892 (ACTUAL)
- **Last updated:** 2015-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090037, "TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01090037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*